行情

CTLT

CTLT

Catalent
NYSE

实时行情|Nasdaq Last Sale

48.93
-1.01
-2.02%
盘后: 48.93 0 0.00% 16:00 04/03 EDT
开盘
49.56
昨收
49.94
最高
50.77
最低
47.59
成交量
78.49万
成交额
--
52周最高
68.78
52周最低
31.04
市值
75.77亿
市盈率(TTM)
55.50
分时
5日
1月
3月
1年
5年

分析师评级

11位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CTLT价格均价为66.50,最高价位75.00,最低价为57.00。

EPS

CTLT 新闻

更多
  • Do Hedge Funds Love Catalent Inc (CTLT)?
  • Insider Monkey · 03/23 05:12
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • What Does Catalent, Inc.'s (NYSE:CTLT) P/E Ratio Tell You?
  • Simply Wall St. · 03/17 12:07
  • A Sliding Share Price Has Us Looking At Catalent, Inc.'s (NYSE:CTLT) P/E Ratio
  • Simply Wall St. · 03/17 11:48

所属板块

制药
-0.14%
制药与医学研究
-0.22%

热门股票

代码
价格
涨跌幅

CTLT 简况

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.
展开

微牛提供Catalent Inc(NYSE-CTLT)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CTLT股票新闻,以帮助您做出投资决策。